Request for Covid-19 Impact Assessment of this Report
The United States Receptor Tyrosine Protein Kinase ERBB 4 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Receptor Tyrosine Protein Kinase ERBB 4 market, reaching US$ million by the year 2028. As for the Europe Receptor Tyrosine Protein Kinase ERBB 4 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Receptor Tyrosine Protein Kinase ERBB 4 players cover Aslan Pharmaceuticals Pte Ltd, Boehringer Ingelheim GmbH, GamaMabs Pharma SA, and Hanmi Pharmaceuticals Co Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Receptor Tyrosine Protein Kinase ERBB 4 market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
PB-357
NT-113
NRG-4
MIN-301
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Skin Cancer
Systolic Heart Failure
Neuroblastoma
Oligodendroglioma
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Aslan Pharmaceuticals Pte Ltd
Boehringer Ingelheim GmbH
GamaMabs Pharma SA
Hanmi Pharmaceuticals Co Ltd
Jiangsu Kanion Pharmaceutical Co Ltd
Minerva Neurosciences Inc
Pfizer Inc
Puma Biotechnology Inc
Shanghai Fosun Pharmaceutical (Group) Co Ltd
XuanZhu Pharma Co Ltd
Zensun (Shanghai) Sci & Tech Co Ltd
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Receptor Tyrosine Protein Kinase ERBB 4 by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Receptor Tyrosine Protein Kinase ERBB 4 by Country/Region, 2017, 2022 & 2028
2.2 Receptor Tyrosine Protein Kinase ERBB 4 Segment by Type
2.2.1 PB-357
2.2.2 NT-113
2.2.3 NRG-4
2.2.4 MIN-301
2.2.5 Others
2.3 Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type
2.3.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type (2017-2022)
2.3.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue and Market Share by Type (2017-2022)
2.3.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Sale Price by Type (2017-2022)
2.4 Receptor Tyrosine Protein Kinase ERBB 4 Segment by Application
2.4.1 Skin Cancer
2.4.2 Systolic Heart Failure
2.4.3 Neuroblastoma
2.4.4 Oligodendroglioma
2.4.5 Others
2.5 Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application
2.5.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sale Market Share by Application (2017-2022)
2.5.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue and Market Share by Application (2017-2022)
2.5.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Sale Price by Application (2017-2022)
3 Global Receptor Tyrosine Protein Kinase ERBB 4 by Company
3.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Breakdown Data by Company
3.1.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Annual Sales by Company (2020-2022)
3.1.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Company (2020-2022)
3.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Annual Revenue by Company (2020-2022)
3.2.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Company (2020-2022)
3.2.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Company (2020-2022)
3.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Sale Price by Company
3.4 Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 4 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 4 Product Location Distribution
3.4.2 Players Receptor Tyrosine Protein Kinase ERBB 4 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Receptor Tyrosine Protein Kinase ERBB 4 by Geographic Region
4.1 World Historic Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Geographic Region (2017-2022)
4.1.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Annual Revenue by Geographic Region
4.2 World Historic Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Country/Region (2017-2022)
4.2.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Annual Sales by Country/Region (2017-2022)
4.2.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Annual Revenue by Country/Region
4.3 Americas Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth
4.4 APAC Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth
4.5 Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth
4.6 Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth
5 Americas
5.1 Americas Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country
5.1.1 Americas Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2017-2022)
5.1.2 Americas Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2017-2022)
5.2 Americas Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type
5.3 Americas Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Receptor Tyrosine Protein Kinase ERBB 4 Sales by Region
6.1.1 APAC Receptor Tyrosine Protein Kinase ERBB 4 Sales by Region (2017-2022)
6.1.2 APAC Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Region (2017-2022)
6.2 APAC Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type
6.3 APAC Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Receptor Tyrosine Protein Kinase ERBB 4 by Country
7.1.1 Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2017-2022)
7.1.2 Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2017-2022)
7.2 Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type
7.3 Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 4 by Country
8.1.1 Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2017-2022)
8.1.2 Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2017-2022)
8.2 Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type
8.3 Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Receptor Tyrosine Protein Kinase ERBB 4
10.3 Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase ERBB 4
10.4 Industry Chain Structure of Receptor Tyrosine Protein Kinase ERBB 4
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Receptor Tyrosine Protein Kinase ERBB 4 Distributors
11.3 Receptor Tyrosine Protein Kinase ERBB 4 Customer
12 World Forecast Review for Receptor Tyrosine Protein Kinase ERBB 4 by Geographic Region
12.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size Forecast by Region
12.1.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Forecast by Region (2023-2028)
12.1.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Receptor Tyrosine Protein Kinase ERBB 4 Forecast by Type
12.7 Global Receptor Tyrosine Protein Kinase ERBB 4 Forecast by Application
13 Key Players Analysis
13.1 Aslan Pharmaceuticals Pte Ltd
13.1.1 Aslan Pharmaceuticals Pte Ltd Company Information
13.1.2 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
13.1.3 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Aslan Pharmaceuticals Pte Ltd Main Business Overview
13.1.5 Aslan Pharmaceuticals Pte Ltd Latest Developments
13.2 Boehringer Ingelheim GmbH
13.2.1 Boehringer Ingelheim GmbH Company Information
13.2.2 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
13.2.3 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Boehringer Ingelheim GmbH Main Business Overview
13.2.5 Boehringer Ingelheim GmbH Latest Developments
13.3 GamaMabs Pharma SA
13.3.1 GamaMabs Pharma SA Company Information
13.3.2 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
13.3.3 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 GamaMabs Pharma SA Main Business Overview
13.3.5 GamaMabs Pharma SA Latest Developments
13.4 Hanmi Pharmaceuticals Co Ltd
13.4.1 Hanmi Pharmaceuticals Co Ltd Company Information
13.4.2 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
13.4.3 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Hanmi Pharmaceuticals Co Ltd Main Business Overview
13.4.5 Hanmi Pharmaceuticals Co Ltd Latest Developments
13.5 Jiangsu Kanion Pharmaceutical Co Ltd
13.5.1 Jiangsu Kanion Pharmaceutical Co Ltd Company Information
13.5.2 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
13.5.3 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Jiangsu Kanion Pharmaceutical Co Ltd Main Business Overview
13.5.5 Jiangsu Kanion Pharmaceutical Co Ltd Latest Developments
13.6 Minerva Neurosciences Inc
13.6.1 Minerva Neurosciences Inc Company Information
13.6.2 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
13.6.3 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Minerva Neurosciences Inc Main Business Overview
13.6.5 Minerva Neurosciences Inc Latest Developments
13.7 Pfizer Inc
13.7.1 Pfizer Inc Company Information
13.7.2 Pfizer Inc Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
13.7.3 Pfizer Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Pfizer Inc Main Business Overview
13.7.5 Pfizer Inc Latest Developments
13.8 Puma Biotechnology Inc
13.8.1 Puma Biotechnology Inc Company Information
13.8.2 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
13.8.3 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Puma Biotechnology Inc Main Business Overview
13.8.5 Puma Biotechnology Inc Latest Developments
13.9 Shanghai Fosun Pharmaceutical (Group) Co Ltd
13.9.1 Shanghai Fosun Pharmaceutical (Group) Co Ltd Company Information
13.9.2 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
13.9.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Shanghai Fosun Pharmaceutical (Group) Co Ltd Main Business Overview
13.9.5 Shanghai Fosun Pharmaceutical (Group) Co Ltd Latest Developments
13.10 XuanZhu Pharma Co Ltd
13.10.1 XuanZhu Pharma Co Ltd Company Information
13.10.2 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
13.10.3 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 XuanZhu Pharma Co Ltd Main Business Overview
13.10.5 XuanZhu Pharma Co Ltd Latest Developments
13.11 Zensun (Shanghai) Sci & Tech Co Ltd
13.11.1 Zensun (Shanghai) Sci & Tech Co Ltd Company Information
13.11.2 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
13.11.3 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Zensun (Shanghai) Sci & Tech Co Ltd Main Business Overview
13.11.5 Zensun (Shanghai) Sci & Tech Co Ltd Latest Developments
14 Research Findings and Conclusion
Table 1. Receptor Tyrosine Protein Kinase ERBB 4 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Receptor Tyrosine Protein Kinase ERBB 4 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of PB-357
Table 4. Major Players of NT-113
Table 5. Major Players of NRG-4
Table 6. Major Players of MIN-301
Table 7. Major Players of Others
Table 8. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type (2017-2022)
Table 10. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2017-2022) & ($ million)
Table 11. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Type (2017-2022)
Table 12. Global Receptor Tyrosine Protein Kinase ERBB 4 Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application (2017-2022)
Table 15. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2017-2022)
Table 16. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Application (2017-2022)
Table 17. Global Receptor Tyrosine Protein Kinase ERBB 4 Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Company (2020-2022)
Table 20. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Company (2020-2022)
Table 22. Global Receptor Tyrosine Protein Kinase ERBB 4 Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 4 Producing Area Distribution and Sales Area
Table 24. Players Receptor Tyrosine Protein Kinase ERBB 4 Products Offered
Table 25. Receptor Tyrosine Protein Kinase ERBB 4 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share Geographic Region (2017-2022)
Table 30. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country/Region (2017-2022)
Table 34. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country (2017-2022)
Table 38. Americas Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country (2017-2022)
Table 40. Americas Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type (2017-2022)
Table 42. Americas Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application (2017-2022)
Table 44. APAC Receptor Tyrosine Protein Kinase ERBB 4 Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Region (2017-2022)
Table 46. APAC Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Region (2017-2022)
Table 48. APAC Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type (2017-2022)
Table 50. APAC Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application (2017-2022)
Table 52. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country (2017-2022)
Table 54. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country (2017-2022)
Table 56. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type (2017-2022)
Table 58. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Receptor Tyrosine Protein Kinase ERBB 4
Table 69. Key Market Challenges & Risks of Receptor Tyrosine Protein Kinase ERBB 4
Table 70. Key Industry Trends of Receptor Tyrosine Protein Kinase ERBB 4
Table 71. Receptor Tyrosine Protein Kinase ERBB 4 Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Receptor Tyrosine Protein Kinase ERBB 4 Distributors List
Table 74. Receptor Tyrosine Protein Kinase ERBB 4 Customer List
Table 75. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Forecast by Region
Table 77. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share Forecast by Application (2023-2028)
Table 95. Aslan Pharmaceuticals Pte Ltd Basic Information, Receptor Tyrosine Protein Kinase ERBB 4 Manufacturing Base, Sales Area and Its Competitors
Table 96. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
Table 97. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. Aslan Pharmaceuticals Pte Ltd Main Business
Table 99. Aslan Pharmaceuticals Pte Ltd Latest Developments
Table 100. Boehringer Ingelheim GmbH Basic Information, Receptor Tyrosine Protein Kinase ERBB 4 Manufacturing Base, Sales Area and Its Competitors
Table 101. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
Table 102. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Boehringer Ingelheim GmbH Main Business
Table 104. Boehringer Ingelheim GmbH Latest Developments
Table 105. GamaMabs Pharma SA Basic Information, Receptor Tyrosine Protein Kinase ERBB 4 Manufacturing Base, Sales Area and Its Competitors
Table 106. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
Table 107. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. GamaMabs Pharma SA Main Business
Table 109. GamaMabs Pharma SA Latest Developments
Table 110. Hanmi Pharmaceuticals Co Ltd Basic Information, Receptor Tyrosine Protein Kinase ERBB 4 Manufacturing Base, Sales Area and Its Competitors
Table 111. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
Table 112. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. Hanmi Pharmaceuticals Co Ltd Main Business
Table 114. Hanmi Pharmaceuticals Co Ltd Latest Developments
Table 115. Jiangsu Kanion Pharmaceutical Co Ltd Basic Information, Receptor Tyrosine Protein Kinase ERBB 4 Manufacturing Base, Sales Area and Its Competitors
Table 116. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
Table 117. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. Jiangsu Kanion Pharmaceutical Co Ltd Main Business
Table 119. Jiangsu Kanion Pharmaceutical Co Ltd Latest Developments
Table 120. Minerva Neurosciences Inc Basic Information, Receptor Tyrosine Protein Kinase ERBB 4 Manufacturing Base, Sales Area and Its Competitors
Table 121. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
Table 122. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 123. Minerva Neurosciences Inc Main Business
Table 124. Minerva Neurosciences Inc Latest Developments
Table 125. Pfizer Inc Basic Information, Receptor Tyrosine Protein Kinase ERBB 4 Manufacturing Base, Sales Area and Its Competitors
Table 126. Pfizer Inc Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
Table 127. Pfizer Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 128. Pfizer Inc Main Business
Table 129. Pfizer Inc Latest Developments
Table 130. Puma Biotechnology Inc Basic Information, Receptor Tyrosine Protein Kinase ERBB 4 Manufacturing Base, Sales Area and Its Competitors
Table 131. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
Table 132. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 133. Puma Biotechnology Inc Main Business
Table 134. Puma Biotechnology Inc Latest Developments
Table 135. Shanghai Fosun Pharmaceutical (Group) Co Ltd Basic Information, Receptor Tyrosine Protein Kinase ERBB 4 Manufacturing Base, Sales Area and Its Competitors
Table 136. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
Table 137. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 138. Shanghai Fosun Pharmaceutical (Group) Co Ltd Main Business
Table 139. Shanghai Fosun Pharmaceutical (Group) Co Ltd Latest Developments
Table 140. XuanZhu Pharma Co Ltd Basic Information, Receptor Tyrosine Protein Kinase ERBB 4 Manufacturing Base, Sales Area and Its Competitors
Table 141. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
Table 142. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 143. XuanZhu Pharma Co Ltd Main Business
Table 144. XuanZhu Pharma Co Ltd Latest Developments
Table 145. Zensun (Shanghai) Sci & Tech Co Ltd Basic Information, Receptor Tyrosine Protein Kinase ERBB 4 Manufacturing Base, Sales Area and Its Competitors
Table 146. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Offered
Table 147. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 148. Zensun (Shanghai) Sci & Tech Co Ltd Main Business
Table 149. Zensun (Shanghai) Sci & Tech Co Ltd Latest Developments
List of Figures
Figure 1. Picture of Receptor Tyrosine Protein Kinase ERBB 4
Figure 2. Receptor Tyrosine Protein Kinase ERBB 4 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Receptor Tyrosine Protein Kinase ERBB 4 Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of PB-357
Figure 10. Product Picture of NT-113
Figure 11. Product Picture of NRG-4
Figure 12. Product Picture of MIN-301
Figure 13. Product Picture of Others
Figure 14. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type in 2021
Figure 15. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Type (2017-2022)
Figure 16. Receptor Tyrosine Protein Kinase ERBB 4 Consumed in Skin Cancer
Figure 17. Global Receptor Tyrosine Protein Kinase ERBB 4 Market: Skin Cancer (2017-2022) & (K Pcs)
Figure 18. Receptor Tyrosine Protein Kinase ERBB 4 Consumed in Systolic Heart Failure
Figure 19. Global Receptor Tyrosine Protein Kinase ERBB 4 Market: Systolic Heart Failure (2017-2022) & (K Pcs)
Figure 20. Receptor Tyrosine Protein Kinase ERBB 4 Consumed in Neuroblastoma
Figure 21. Global Receptor Tyrosine Protein Kinase ERBB 4 Market: Neuroblastoma (2017-2022) & (K Pcs)
Figure 22. Receptor Tyrosine Protein Kinase ERBB 4 Consumed in Oligodendroglioma
Figure 23. Global Receptor Tyrosine Protein Kinase ERBB 4 Market: Oligodendroglioma (2017-2022) & (K Pcs)
Figure 24. Receptor Tyrosine Protein Kinase ERBB 4 Consumed in Others
Figure 25. Global Receptor Tyrosine Protein Kinase ERBB 4 Market: Others (2017-2022) & (K Pcs)
Figure 26. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application (2017-2022)
Figure 27. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Application in 2021
Figure 28. Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market by Company in 2021 ($ Million)
Figure 29. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Company in 2021
Figure 30. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Geographic Region (2017-2022)
Figure 31. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Geographic Region in 2021
Figure 32. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Region (2017-2022)
Figure 33. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country/Region in 2021
Figure 34. Americas Receptor Tyrosine Protein Kinase ERBB 4 Sales 2017-2022 (K Pcs)
Figure 35. Americas Receptor Tyrosine Protein Kinase ERBB 4 Revenue 2017-2022 ($ Millions)
Figure 36. APAC Receptor Tyrosine Protein Kinase ERBB 4 Sales 2017-2022 (K Pcs)
Figure 37. APAC Receptor Tyrosine Protein Kinase ERBB 4 Revenue 2017-2022 ($ Millions)
Figure 38. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales 2017-2022 (K Pcs)
Figure 39. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue 2017-2022 ($ Millions)
Figure 40. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales 2017-2022 (K Pcs)
Figure 41. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 4 Revenue 2017-2022 ($ Millions)
Figure 42. Americas Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country in 2021
Figure 43. Americas Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country in 2021
Figure 44. United States Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth 2017-2022 ($ Millions)
Figure 45. Canada Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth 2017-2022 ($ Millions)
Figure 46. Mexico Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth 2017-2022 ($ Millions)
Figure 47. Brazil Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth 2017-2022 ($ Millions)
Figure 48. APAC Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Region in 2021
Figure 49. APAC Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Regions in 2021
Figure 50. China Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth 2017-2022 ($ Millions)
Figure 51. Japan Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth 2017-2022 ($ Millions)
Figure 52. South Korea Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth 2017-2022 ($ Millions)
Figure 53. Southeast Asia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth 2017-2022 ($ Millions)
Figure 54. India Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth 2017-2022 ($ Millions)
Figure 55. Australia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth 2017-2022 ($ Millions)
Figure 56. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country in 2021
Figure 57. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country in 2021
Figure 58. Germany Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth 2017-2022 ($ Millions)
Figure 59. France Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth 2017-2022 ($ Millions)
Figure 60. UK Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth 2017-2022 ($ Millions)
Figure 61. Italy Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth 2017-2022 ($ Millions)
Figure 62. Russia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth 2017-2022 ($ Millions)
Figure 63. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country in 2021
Figure 64. Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country in 2021
Figure 65. Egypt Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth 2017-2022 ($ Millions)
Figure 66. South Africa Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth 2017-2022 ($ Millions)
Figure 67. Israel Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth 2017-2022 ($ Millions)
Figure 68. Turkey Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth 2017-2022 ($ Millions)
Figure 69. GCC Country Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth 2017-2022 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Receptor Tyrosine Protein Kinase ERBB 4 in 2021
Figure 71. Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase ERBB 4
Figure 72. Industry Chain Structure of Receptor Tyrosine Protein Kinase ERBB 4
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...